NVIDIA – How GPU-Powered Cellular Analysis Could Help Avoid Unnecessary Prostate Cancer Biopsies
1.3M North American men get biopsies each year checking for prostate cancer, many of them unnecessary. UofA researchers want to change that with a new test that relies on GPU computing.
Startup Nanostics preparing launch of blood-based biomarker test for prostate cancer
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
New blood test uses nanotechnology to predict prostate cancer
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
U of A uses nanotechnology to develop new test for aggressive prostate cancer
Alberta men diagnosed with prostate cancer could soon have a better blood test to help determine if they can bypass a painful and invasive biopsy.
Could there soon be a better way to protect against prostate cancer?
The PSA test for prostate cancer has been linked to unnecessary treatments and biopsies. That’s prompted researchers to start developing a more accurate prostate cancer detection tool.
